Send feedback

TELO2 p.Ser20=

c.60G>A · rs140140646 · VCV729753

Likely benign Multiple submitters
Classification
Likely benign
ClinVar
Review
Multiple submitters ★★☆☆
ClinVar · 2 submitters
gnomAD v4.1
Rare
ultra-rare (popmax 0.0461%, nfe)

Computational evidence

Protein change
Missense predictors do not apply to this variant type; conservation carries the signal.
Splicing
SpliceAI—not assessed · no allele here is in the release
Constraint at this position
ConservationphyloP -2.3GERP -4.2
Overall
CADD0.248PHRED · no single calibrated threshold — expert panels disagree

Population frequency

gnomAD v4.1 · exomes + genomes
Grpmax group 0.0461% European (non-Finnish) · 544/1,180,014 alleles
Filtering AF 0.0429% ClinGen BA1/BS1 input FAF95, joint · FAF99 0.0415%
Overall 0.0357% 576/1,613,646 alleles · ultra-rare
Ancestry group Frequency 1 in
European (non-Finnish)grpmax 0.0461% 2,169
Remaining individualsnot grpmax-eligible 0.0288% 3,473
Admixed American 0.00833% 12,002
African / African-American 0.008% 12,498
Finnishnot grpmax-eligible 0.00314% 31,798
South Asian 0.0011% 91,066

Rarity supports pathogenicity (ACMG PM2); frequency above a disease-specific BA1/BS1 threshold argues against it. A variant frequent in one ancestry group can be near-absent in others, so a single global figure can mislead.

Variant & gene context

Gene
TELO2
Protein
p.Ser20=
Coding
c.60G>A
MANE Select
NM_016111
dbSNP
rs140140646
Type
single nucleotide variant
Location
chr16:1494341 (GRCh38)
Gene constraint
LOEUF 1.03 · pLI <0.01 (gnomAD)
Structure
AlphaFold pLDDT 84.74 · 4 PDB
Residue 20
an α-helix
Full TELO2 gene report on Sugi Atlas → Gene function, pathways, protein structure, interactions & more

Similar variants

Built on 18 open, versioned datasets — ClinVar, gnomAD, AlphaMissense, REVEL, ClinGen & more — plus Sugi Variant's own cross-source analysis. Source data 2026-01–2026-10, ClinVar 2026-10. Full sources & versions →

Cite Sugi Variant

Gür T. Sugi Variant: A Deterministic Per-Variant Germline Reference from a Knowledge Graph for Humans and AI Agents. 2026. doi:10.5281/zenodo.21509445. This variant: https://sugi.bio/variant/telo2-p-ser20 (accessed [today's date]).

Preprint & method: sugi.bio/variant/method Machine-readable: this page as Markdown